GILD
Gilead Sciences, Inc. β’ Healthcare (#8 of 11)
$123.76
-1.69 (-1.35%)
View:
Close:$123.76
Vol:EXTREME(90%ile)
Ratio:1.49x
|RSI:39(Neutral)
MACD:β
β₯75%25-75%<25%
Vol.%
Sector Rotation
2026-06-18(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRALβ²1 UpβΌ0 Down1 Hold
Jun 16Cantor Fitzgerald
βOverweight
May 20Maxim Group
β²Hold β Buy
Price Targets
β²0 RaisesβΌ0 Lowers
Jun 16Cantor Fitzgerald
$155β$155New
May 20Maxim Group
$165New
Trade Setup
ATR-basedEntry$123.76
Target$131.00 (+5.9%)
Stop$118.33
R/R1.33
Risk-4.4%
ATR$3.62
Simple setup: 1.5x ATR stop, 2x ATR target
Risk Metrics
Sharpe (20d)
-1.90Losing
Volatility (20d)
29.5%Normal
Beta (60d)
0.58Defensive
Alpha (20d)
-5.6%Weak
News Analysis
EN
δΈ
ν
ζ₯
No analysis record found.